Skip to main content
. 2021 Sep 29;9(2):e00733-21. doi: 10.1128/Spectrum.00733-21

TABLE 2.

Genscript cPass surrogate virus neutralization test in parallel and series testing with other serological assays

Assay with Genscript cPass Parallel testing (%)
Series testing (%)
Sensitivity Specificity Sensitivity Specificity
Diasorin-S1/S2 IgG 92.86 89.07 53.53 99.69
Alinity IgG II 99.46 66.8 69.65 98.41
Diasorin-TrimericS IgG 95.63 85.17 60.27 99.46
Roche Elecsys 100 39.72 71 96.9
AESKULISA 97.77 68.46 65.54 98.52